Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Stephanie Henry"'
Autor:
Keiko A. Fukuda, Kavit Shah, Cynthia Kenmuir, Derrick Barnagian, Baraa Nawash, Shashvat Desai, Marcelo Rocha, Matthew Starr, Eileen Roach, Stephanie Henry, Bradley J. Molyneaux, Ashutosh P. Jadhav
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 4, Iss 3 (2024)
Background Our health care systems continue to face significant strain due to chronically taxed intensive care resources. A subgroup of patients following thrombolytic stroke may not require prolonged intensive monitoring, alleviating some burden. He
Externí odkaz:
https://doaj.org/article/d8737377a84d4215985b154110a4c5f2
Autor:
Dae-Hee Lee, Ying Zhang, Amin B Kassam, Myung-Jin Park, Paul Gardner, Daniel Prevedello, Stephanie Henry, Craig Horbinski, Jan H Beumer, Hussein Tawbi, Brian J Williams, Mark E Shaffrey, Merrill J Egorin, Roger Abounader, Deric M Park
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134426 (2015)
The majority of chordomas show activation of the platelet-derived growth factor receptor (PDGFR). Based on in vitro intertumoral variation in response to recombinant PDGF protein and PDGFR inhibition, and variable tumor response to imatinib, we hypot
Externí odkaz:
https://doaj.org/article/b9e40afa3cfc436788788ef2f5fd5a4d
Autor:
Ann-Charlotte Granholm, Stephanie Henry, Meleik A. Hebert, Servet Eken, Greg A. Gerhardt, Craig Van Horne
Publikováno v:
Cell Transplantation, Vol 7 (1998)
Recent studies have demonstrated the presence of many different neurotrophic factors in the developing and adult kidney. Due to its production of this mixture of neurotrophic factors, we wanted to investigate whether fetal kidney tissue could be bene
Externí odkaz:
https://doaj.org/article/89209fdcc3f04e52a486743dd39fefc5
Autor:
Keiko A Fukuda, Kavit Shah, Cynthia Kenmuir, Derrick Barnagian, Baraa Nawash, Mackenzie Nelson, Shashvat Desai, Marcelo Rocha, Matthew Starr, Eileen Roach, Stephanie Henry, Bradley J Molyneaux, Ashutosh P Jadhav
IntroductionOur health care systems continue to face significant strain due to chronically taxed intensive care resources. A subgroup of post-thrombolytic stroke patients may not require prolonged intensive monitoring, alleviating some burden. Here w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e9139125d2a66ea629d287cb0634588
https://doi.org/10.1101/2023.03.27.23287831
https://doi.org/10.1101/2023.03.27.23287831
Autor:
Javier Carrasco, Claire Quaghebeur, Stephanie Henry, Christine Galant, Mieke Van Bockstal, Paul Delrée, Brigitte Honhon, Dominique Korman, Vincent Verschaeve, Christophe Lonchay, Sarah Levefre, Lionel D'hondt, Martine Berliere, Sophie Delmarcelle, Jean-Michel Mine, Timour Willems, Gebhard Müller, Nathalie Myant, Isabelle Bar, Manuel Constant, Sandy Haussy, Alix Devaux, Pierre Coulie, Jean-Luc Canon, François Duhoux
Publikováno v:
Cancer Research. 82:P2-14
Background: The association of immune checkpoints inhibitors (ICI) and dose dense chemotherapy is a promising combination in a neoadjuvant setting for triple negative breast cancers (TNBC). However, response rates vary from one study to another and t
Autor:
Philipp Harter, Frederik Marmé, Klaus Pietzner, Alexander Reuss, Isabelle Ray-Coquard, Andrés Redondo, Ana Oaknin, Goda Jonuskiene, Kristina Lindemann, Christian Kurzeder, Jens Huober, Els van Nieuwenhuysen, Stephanie Henry, Christian Marth, Irina Tsibulak, Nadin Cron, Patricia Pautier
Publikováno v:
Ovarian cancer.
Autor:
Isaura Fernandez-Perez, Pier Adelchi Ruffini, Giuseppe Viale, Beth Butler, Jenny C. Chang, Mauro Mansutti, Christelle Levy, Susan McCanna, Anne F. Schott, Stephanie Henry, Lori J. Goldstein, Guiseppe Viale, Max S. Wicha
Publikováno v:
Cancer Research. 80:P3-11
Background: CXCR1, one of the receptors for CXCL8, has been identified as a druggable target on breast cancer Cancer Stem Cells (CSC): In a phase 1b study, the combination of reparixin (R), an investigational oral inhibitor of CXCR1, and weekly pacli
Autor:
Joyce O’Shaughnessy, Adam Brufsky, Hope S. Rugo, Sara M. Tolaney, Kevin Punie, Sagar Sardesai, Erika Hamilton, Delphine Loirat, Tiffany Traina, Roberto Leon-Ferre, Sara A. Hurvitz, Kevin Kalinsky, Aditya Bardia, Stephanie Henry, Ingrid Mayer, Yanni Zhu, See Phan, Javier Cortés
Publikováno v:
Breast cancer research and treatment, Vol. 195, no. 2, p. 127-139 (2022)
Breast cancer research and treatment, vol 195, iss 2
Breast cancer research and treatment, vol 195, iss 2
Purpose Sacituzumab govitecan (SG) is an antibody–drug conjugate composed of an anti–Trop-2 antibody coupled to SN-38 via a proprietary hydrolyzable linker. In the ASCENT study, SG improved survival versus single-agent treatment of physician’s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6facd6f5b366ddc5ea63d4f43838e216
https://hdl.handle.net/2078.1/260771
https://hdl.handle.net/2078.1/260771
Publikováno v:
International Journal of Healthcare Simulation.
Premature infants are at risk of death or neurodevelopmental impairment unless prompt effective care is delivered The aim of the study was to introduce a recurring virtual simulation workshop for WMAS on optimizing the initial care for vulnerable pre
Autor:
Ugo De Giorgi, Bohuslav Melichar, Bente Lund, Signe Diness Vindeløv, Antonio González-Martín, Jeffrey R. Harris, Francesco Raspagliesi, Michael Gold, Claudio Zamagni, Andrés Redondo, Nicole Concin, Brigitte Honhon, Maria Bjurberg, Sandro Pignata, Melinda S L Teng, Matthew Schlumbrecht, Meaghan Tenney, Mansoor Raza Mirza, Reshma A. Rangwala, Charles Leath, Robert L. Coleman, Domenica Lorusso, Annouschka Laenen, Eveline De Cuypere, Lydia Gaba Garcia, Giovanni Scambia, Sven Mahner, William H. Bradley, Carolyn Muller, Nicola Spirtos, Margaret Smith, David Cibula, Leslie M Randall, Bradley J. Monk, Philipp Harter, Stephanie Henry, Sumeet Bhatia, Joshua Cohen, Menghui Chen, Christine Gennigens, Ignace Vergote, Luis Manso, Zdenek Kral, Amanda Jackson, Robin Farias-Eisner, Jean-Francois Baurain, Christof Vulsteke, David M. O'Malley, Frederic Forget, Linn Woelber, Mary Gordinier, Hannelore Denys, Leonardo Viana Nicacio
Publikováno v:
Coleman, R L, Lorusso, D, Gennigens, C, González-Martín, A, Randall, L, Cibula, D, Lund, B, Woelber, L, Pignata, S, Forget, F, Redondo, A, Vindeløv, S D, Chen, M, Harris, J R, Smith, M, Nicacio, L V, Teng, M S L, Laenen, A, Rangwala, R, Manso, L, Mirza, M, Monk, B J, Vergote, I & The innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators 2021, ' Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6) : a multicentre, open-label, single-arm, phase 2 study ', The Lancet Oncology, vol. 22, no. 5, pp. 609-619 . https://doi.org/10.1016/S1470-2045(21)00056-5
Summary Background Few effective second-line treatments exist for women with recurrent or metastatic cervical cancer. Accordingly, we aimed to evaluate the efficacy and safety of tisotumab vedotin, a tissue factor-directed antibody–drug conjugate,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::602debc1a5b7e94c93fe44ed1aa57b6a
https://vbn.aau.dk/da/publications/b1ba31e5-0840-4941-91b2-2218550c4b91
https://vbn.aau.dk/da/publications/b1ba31e5-0840-4941-91b2-2218550c4b91